RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease. by Adam M Weidner, Melissa A Bradley, Tina L Beckett, Dana M Niedowicz, Amy L S Dowling, Sergey V Matveev, Harry LeVine, Mark A Lovell, M Paul Murphy

Get full text

Perspectives on eye care access and telemedicine-based glaucoma screening among Latine individuals with limited English proficiency by Norma E. Del Risco, Mildred Silva Zuccaro, Jade J. Livingston, Michele Heisler, Harry Levine, Maria A. Woodward, Amanda K. Bicket, Angela R. Elam, Denise A. John, Paula Anne Newman-Casey

Get full text

Preserving Phase Coherence and Linearity in Cat Qubits with Exponential Bit-Flip Suppression by Harald Putterman, Kyungjoo Noh, Rishi N. Patel, Gregory A. Peairs, Gregory S. MacCabe, Menyoung Lee, Shahriar Aghaeimeibodi, Connor T. Hann, Ignace Jarrige, Guillaume Marcaud, Yuan He, Hesam Moradinejad, John Clai Owens, Thomas Scaffidi, Patricio Arrangoiz-Arriola, Joe Iverson, Harry Levine, Fernando G. S. L. Brandão, Matthew H. Matheny, Oskar Painter

Get full text

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity. by Nicholas J Izzo, Jinbin Xu, Chenbo Zeng, Molly J Kirk, Kelsie Mozzoni, Colleen Silky, Courtney Rehak, Raymond Yurko, Gary Look, Gilbert Rishton, Hank Safferstein, Carlos Cruchaga, Alison Goate, Michael A Cahill, Ottavio Arancio, Robert H Mach, Rolf Craven, Elizabeth Head, Harry LeVine, Tara L Spires-Jones, Susan M Catalano

Get full text